pISSN 2636-0004
eISSN 2636-0012

Table. 1.

Summary of Representative Published Data on EUS-Guided Ethanol Ablation for Neuroendocrine Tumors

Study No. of patients Indication Size (mm)* Needle (gauge) Ethanol (%) Session Result Adverse events
Jürgensen et al9 (2006) 1 Insulinoma 13 22 95 1 No recurrence at 34 mo Mild pancreatitis
Muscatiello et al10 (2008) 1 2 nonfunctional NET 7, 11 NA 40 2 No recurrence at 18 mo Necrotizing pancreatitis
Deprez et al11 (2008) 1 Insulinoma NA NA 98 1 No recurrence at 24 mo Mild pancreatitis, duodenal wall hematoma and ulceration
Vleggaar et al12 (2011) 1 Insulinoma 9 25 96 1 Decreased size, asymptomatic at 6 mo None
Levy et al13 (2012) 5 Insulinoma 8, 16, 18, 20, 21 22, 25 95, 98, 99 2 (n = 4), 3 (n = 1) 3 asymptomatic, 2 improved symptoms None
Qin et al14 (2014) 4 Insulinoma 5.4, 10, 10, 11.8 25 95 1 4 asymptomatic None
Park et al15 (2015) 11 10 nonfunctional NET, 4 insulinoma 12.3 (8–19) 22 99 1 (n = 6), 2 (n = 3), 3 (n = 2) 9 complete response, 4 partial response, 1 excluded Mild pancreatitis, pancreatic duct stricture
de Sousa Lages et al16 (2017) 1 Insulinoma 12 NA 95 1 1 asymptomatic None

EUS, endoscopic ultrasound; NET, neuroendocrine tumor; NA, not available.

*Number or mean (range).

Int J Gastrointest Interv 2020;9:135~141 https://doi.org/10.18528/ijgii200036
© Int J Gastrointest Interv